AI-Driven Disease Modeling Takes Focus at JSMO 2026

At JSMO 2026 in Yokohama, BostonGene shared how its disease modeling platform is helping advance precision oncology. By integrating diverse data sources, the approach supports better prediction of treatment outcomes, improved clinical trial design, and more informed therapeutic decisions. The model is increasingly being used by biopharma partners to strengthen research and patient care.

Read more on how AI is transforming oncology and drug development: https://bostongene.com/news-an....d-publications/news/

AI and Multiomics Powering Next-Gen Cancer Therapies

In a strategic collaboration, BostonGene and ImmunoGenesis are leveraging advanced AI and multiomic technologies to enhance the clinical development of IMGS-001. This innovative approach focuses on understanding tumor biology at a deeper level, helping identify which patients are most likely to benefit from treatment while improving the overall effectiveness of immunotherapy.

Learn how cutting-edge technologies are reshaping cancer treatment strategies: https://bostongene.com/news-an....d-publications/news/

BostonGene Showcases AI-Driven Breakthroughs at AACR 2026

BostonGene will present 13 abstracts at the AACR Annual Meeting 2026, highlighting its advanced AI-powered platform for tumor and immune biology. The company’s innovations focus on accelerating drug discovery, improving patient stratification, and reducing clinical development risks through multiomic data integration and cutting-edge analytics.

Explore the full announcement here: https://bostongene.com/news-an....d-publications/news/

New Research Expands Treatment Possibilities in Advanced Cancers

Emerging research showcases how next-generation molecular profiling is helping uncover hidden treatment opportunities in patients with advanced cancers. By going beyond traditional testing methods, this approach enables the discovery of new therapeutic targets and broadens access to more personalized care options.

Read the full press release to learn more about these findings and their impact on the future of cancer treatment. https://bostongene.com/news-an....d-publications/news/

AI is playing a big role in oncology research right now.

BostonGene is working with Ottimo Pharma to accelerate development of a new immuno oncology therapy using advanced analytics and multiomic data.

More details here:
https://bostongene.com/news-an....d-publications/news/